Follow The Filings

RMD ResMed

ResMed earnings company data as of 4:46 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 2.73 — —
Rev — — —

Insider trades

Open-market buys and sales by RMD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RMD insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $22.3M sold by 5 insiders under 10b5-1 plans
  1. Michael J. Farrell CEO
    Planned sale
    $1.1M 4,991 shares at $226.33 1% of stake
    Traded Oct 7 Filed Oct 8
    ↗
  2. Michael J. Farrell CEO
    Planned sale
    $1.1M 4,991 shares at $222.44 1.1% of stake
    Traded Sep 8 Filed Sep 10
    ↗
  3. Peter C Farrell Director
    Planned sale
    $228K 970 shares at $234.73 1.8% of stake
    Traded Sep 2 Filed Sep 4
    ↗
  4. Michael J. Farrell CEO
    Planned sale
    $1M 4,991 shares at $205.69 1.1% of stake
    Traded Aug 7 Filed Aug 11
    ↗
  5. Peter C Farrell Director
    Planned sale
    $1.8M 8,000 shares at $225.00 13% of stake
    Traded Aug 5 Filed Aug 6
    ↗
  6. Michael J. Farrell CEO
    Planned sale
    $1.1M 4,991 shares at $218.55 1.1% of stake
    Traded Jul 7 Filed Jul 9
    ↗
  7. Michael J. Farrell CEO
    Planned sale
    $968K 4,991 shares at $193.96 1.1% of stake
    Traded Jun 8 Filed Jun 9
    ↗
  8. Michael J. Farrell CEO
    Planned sale
    $1M 4,991 shares at $207.82 1.1% of stake
    Traded May 7 Filed May 11
    ↗
  9. Michael J. Farrell CEO
    Planned sale
    $1.1M 4,991 shares at $225.50 1.1% of stake
    Traded Apr 7 Filed Apr 9
    ↗
  10. Brett Sandercock CFO
    Planned sale
    $224K 1,000 shares at $224.31 1.2% of stake
    Traded Apr 1 Filed Apr 3
    ↗
  11. Peter C Farrell Director
    Planned sale
    $450K 2,000 shares at $225.00 3.2% of stake
    Traded Apr 1 Filed Apr 2
    ↗
  12. Michael J. Farrell CEO
    Planned sale
    $1.3M 4,991 shares at $251.03 1.1% of stake
    Traded Mar 9 Filed Mar 11
    ↗
  13. Peter C Farrell Director
    Planned sale
    $520K 2,000 shares at $260.22 3.1% of stake
    Traded Mar 4 Filed Mar 5
    ↗
  14. Brett Sandercock CFO
    Planned sale
    $254K 1,000 shares at $254.30 1.2% of stake
    Traded Mar 2 Filed Mar 3
    ↗
  15. Michael J. Farrell CEO
    Planned sale
    $1.4M 4,991 shares at $273.78 1.1% of stake
    Traded Feb 9 Filed Feb 10
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 stock grants, 15 option exercises, and 13 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 8.01 Filing Doc
8-K 4.01,5.02,7.01,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.